HYBRID Thesis Defense: Wei Meng (Immunology Program) – “Mass Spectrometry Based Discovery of Tumor Antigens for Cancer Immunotherapy”

August 1, 2023
11:00 am - 12:00 pm
Zoom/Connor Auditorium (Farrell LTC, Medical Campus)

“Mass Spectrometry Based Discovery of Tumor Antigens for Cancer Immunotherapy”


Thesis lab: Robert Schreiber (WashU Pathology & Immunology)

For inquiries contact Wei Meng.